1. Home
  2. RAVE vs PLUR Comparison

RAVE vs PLUR Comparison

Compare RAVE & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

HOLD

Current Price

$2.83

Market Cap

38.5M

ML Signal

HOLD

Logo Pluri Inc.

PLUR

Pluri Inc.

HOLD

Current Price

$3.40

Market Cap

34.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
PLUR
Founded
1958
2001
Country
United States
Israel
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.5M
34.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RAVE
PLUR
Price
$2.83
$3.40
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
63.5K
57.7K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
9.08
N/A
EPS
0.20
N/A
Revenue
$12,202,000.00
$1,326,000.00
Revenue This Year
N/A
$97.38
Revenue Next Year
N/A
$293.97
P/E Ratio
$14.66
N/A
Revenue Growth
0.73
121.74
52 Week Low
$2.01
$3.20
52 Week High
$3.75
$7.13

Technical Indicators

Market Signals
Indicator
RAVE
PLUR
Relative Strength Index (RSI) 46.61 41.43
Support Level $2.84 $3.20
Resistance Level $3.19 $3.94
Average True Range (ATR) 0.21 0.35
MACD -0.01 -0.02
Stochastic Oscillator 9.09 13.21

Price Performance

Historical Comparison
RAVE
PLUR

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About PLUR Pluri Inc.

Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.

Share on Social Networks: